The company shows low valuation levels, with an enterprise value at 0.33 times its sales.
Its low valuation, with P/E ratio at 10.31 and 8.45 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
Weaknesses
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company does not generate enough profits, which is an alarming weak point.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last few months, analysts have been revising downwards their earnings forecast.
For the past year, analysts have significantly revised downwards their profit estimates.